Description

This issue of Vital Signs, released on August 31, 2013, explores the needs of an ever-expanding healthcare IT and interactive domain in a patient-centric model and identifies the criteria for true intelligent systems that are defining new approaches to care, facilitating the gathering and array of health information, including population management analytics that ultimately integrate with healthcare finance protocols to support rational decision-making for cost containment.

Additionally, a company spotlight is provided for GenomeDx Biosciences in Vancouver, BC. The company has developed the Decipher Prostate Cancer Classifier test to predict the metastatic risk for patients that have undergone a prostatectomy as treatment or the surgical removal of the prostate gland.